(Reuters) – The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and Human Services said on Tuesday.
The company will raise the domestic production of COVID-19 test kits to 100,000 per day by March 2021 under the deal and deliver 6 million tests and 30,000 instruments to the government to support its response to the pandemic, the health agency said.
The point-of-care test can detect the novel coronavirus in about 20 minutes with nasal swab samples collected using a Sample Wand from the lower part of the nose, the HHS said.
The system also allows results to be sent to a mobile phone via an app.
The company’s test kit was approved by the U.S. Food and Drug Administration (FDA) in
A Rochester Institute of Technology professor has been recognized for excellence in research by the Society for Sedimentary Geology. RIT Associate Provost for Faculty Affairs Carmala Garzione received the 2020 William R. Dickinson Medal.
The society’s citation said it awarded this medal “in recognition of Carmala Garzione’s pioneering work in developing stable isotope methods for determination of paleoelevation, her contributions to orogenic history and paleoclimate by leveraging the stratigraphic record, and her energetic leadership and service to the geosciences community.” Each year the medal is awarded to recognize a mid-career research geoscientist who is significantly influencing the sedimentary geology community with innovative work and with a track record of impactful publications, pioneering approaches, and the establishment of an influential research program.
Garzione’s research focuses on the tectonic and climate evolution of sedimentary basins and related mountain belts. Large mountain belts have a significant impact on global climate and geochemical budgets.